| SC 13G/A | 2024-02-14 | Point72 Asset Management, L.P. | Syndax Pharmaceuticals Inc | 2,834,499 | 3.3% | EDGAR |
| SC 13G | 2024-02-14 | Kynam Capital Management, LP | Syndax Pharmaceuticals Inc | 5,660,000 | 6.7% | EDGAR |
| SC 13G/A | 2024-02-13 | Avidity Partners Management LP | Syndax Pharmaceuticals Inc | 3,950,000 | 4.7% | EDGAR |
| SC 13G | 2024-02-13 | VANGUARD GROUP INC | Syndax Pharmaceuticals Inc | 4,335,353 | 5.1% | EDGAR |
| SC 13G/A | 2024-02-08 | WELLINGTON MANAGEMENT GROUP LLP | Syndax Pharmaceuticals Inc | 7,585,221 | 8.9% | EDGAR |
| SC 13G/A | 2024-01-25 | STATE STREET CORP | Syndax Pharmaceuticals Inc | - | 5.9% | EDGAR |
| SC 13G/A | 2024-01-25 | BlackRock Inc. | Syndax Pharmaceuticals Inc | 7,015,548 | 8.3% | EDGAR |
| SC 13G | 2023-10-31 | Point72 Asset Management, L.P. | Syndax Pharmaceuticals Inc | 3,156,982 | 4.5% | EDGAR |
| SC 13G/A | 2023-10-05 | Frazier Life Sciences Public Fund, L.P. | Syndax Pharmaceuticals Inc | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Avidity Partners Management LP | Syndax Pharmaceuticals Inc | 6,718,142 | 9.7% | EDGAR |
| SC 13G/A | 2023-02-14 | BIOTECHNOLOGY VALUE FUND L P | Syndax Pharmaceuticals Inc | 777,173 | 1.1% | EDGAR |
| SC 13G/A | 2023-02-14 | Nantahala Capital Management, LLC | Syndax Pharmaceuticals Inc | 975,705 | 1.4% | EDGAR |
| SC 13G/A | 2023-02-14 | Frazier Life Sciences Public Fund, L.P. | Syndax Pharmaceuticals Inc | 2,401,503 | 3.5% | EDGAR |
| SC 13G/A | 2023-02-06 | STATE STREET CORP | Syndax Pharmaceuticals Inc | - | 5.4% | EDGAR |
| SC 13G/A | 2023-02-01 | BlackRock Inc. | Syndax Pharmaceuticals Inc | 4,352,032 | 6.4% | EDGAR |
| SC 13G | 2023-01-10 | WELLINGTON MANAGEMENT GROUP LLP | Syndax Pharmaceuticals Inc | 7,983,442 | 11.7% | EDGAR |
| SC 13D/A | 2022-03-04 | Access Industries Holdings LLC | Syndax Pharmaceuticals Inc | 2,603,709 | - | EDGAR |
| SC 13G/A | 2022-02-14 | Avidity Partners Management LP | Syndax Pharmaceuticals Inc | 5,244,019 | 9.9% | EDGAR |
| SC 13G/A | 2022-02-14 | BIOTECHNOLOGY VALUE FUND L P | Syndax Pharmaceuticals Inc | 2,514,836 | 4.7% | EDGAR |
| SC 13G | 2022-02-14 | Nantahala Capital Management, LLC | Syndax Pharmaceuticals Inc | 3,050,559 | 5.8% | EDGAR |